Published in Gut on April 01, 1993
Abundance of surfactant-like particles reflects mucosal integrity in patients with peptic ulcer disease. Gut (1996) 0.77
Acute effects of high-dose intragastric nicotine on mucosal defense mechanisms: an analysis of nicotine, prostaglandin E2, phospholipase A2, and phospholipids. Dig Dis Sci (1997) 0.77
Influence of smoking and Helicobacter pylori on gastric phospholipids. Dig Dis Sci (2000) 0.76
Gastric mucosal phospholipids and gastroduodenal diseases. Gut (1993) 0.75
NMR-based metabolomics Reveals Alterations of Electro-acupuncture Stimulations on Chronic Atrophic Gastritis Rats. Sci Rep (2017) 0.75
Phospholipid Complex Technique for Superior Bioavailability of Phytoconstituents. Adv Pharm Bull (2017) 0.75
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Role of surface-active phospholipids in gastric cytoprotection. Science (1983) 1.45
Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach. Am J Physiol (1983) 1.45
Lipid composition of the gastric mucous barrier in the rat. J Biol Chem (1978) 1.28
Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut (1987) 1.13
Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa. Gastroenterology (1985) 1.08
Lipid binding to gastric mucin: protective effect against oxygen radicals. Am J Physiol (1990) 1.08
Molecular species of phosphatidylcholine from rat gastric mucosa. Biochim Biophys Acta (1979) 1.05
Water repellency induced by pulmonary surfactants. J Physiol (1982) 1.05
Surfactant approach to the gastric mucosal barrier: protection of rats by banana even when acidified. Gastroenterology (1989) 1.01
Does aspirin damage canine gastric mucosa by reducing its surface hydrophobicity? Am J Physiol (1987) 0.97
Exogenous surface-active phospholipid protects Necturus gastric mucosa against luminal acid and barrier-breaking agents. Gastroenterology (1991) 0.95
Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate. Am J Physiol (1983) 0.94
Hydrogen ion diffusion in dog gastric mucus glycoprotein: effect of associated lipids and covalently bound fatty acids. Biochem Biophys Res Commun (1984) 0.90
Phospholipids from rat, human, and canine gastric mucosa. Composition and metabolism of molecular classes of phosphatidylcholine. Gastroenterology (1990) 0.88
Effect of lipids and proteins on the viscosity of gastric mucus glycoprotein. Biochem Biophys Res Commun (1984) 0.87
Gastric mucosal barrier: hydrophobicity of stretched stomach lining. Am J Physiol (1985) 0.83
Ganglioside dependent return of TSH receptor function in a rat thyroid tumor with a TSH receptor defect. Biochem Biophys Res Commun (1983) 0.83
Coeliac disease and unfavourable outcome of pregnancy. Gut (2000) 2.31
Multicomponent structure of the thyrotropin receptor: relationship to Graves' disease. Life Sci (1983) 1.48
Lipids of human gastric mucosa: effect of Helicobacter pylori infection and nonalcoholic cirrhosis. Gastroenterology (1994) 1.48
Interactions between metabolic disorders (diabetes, gallstones, and dyslipidaemia) and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma. A cross-sectional multicentre survey. Dig Liver Dis (2001) 1.42
Clinical nutrition practice in Italian Gastroenterology Units. Dig Liver Dis (2001) 1.42
Treatment of chronic hepatitis C with recombinant interferon alfa. Ital J Gastroenterol (1992) 1.39
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13
The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther (1999) 1.12
Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol (2001) 1.12
Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships. Scand J Gastroenterol (2001) 1.09
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther (2005) 1.05
Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase. Clin Chem (1994) 1.03
Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatology (1996) 1.00
Reflux oesophagitis in adult coeliac disease: beneficial effect of a gluten free diet. Gut (2003) 1.00
Gastrokine 1 expression in patients with and without Helicobacter pylori infection. Dig Liver Dis (2006) 0.99
Cirrhosis negatively affects the efficiency of serologic diagnosis of Helicobacter pylori infection. Ital J Gastroenterol (1997) 0.96
Investigation of intestine and liver function in cirrhosis using combined sugar oral loads. J Hepatol (1985) 0.94
Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut (1990) 0.93
Serum gastrin in patients with cirrhosis of the liver. Digestion (1974) 0.92
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. J Clin Endocrinol Metab (1983) 0.90
A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells. Proc Natl Acad Sci U S A (1999) 0.90
A human, compact, fully functional anti-ErbB2 antibody as a novel antitumour agent. Br J Cancer (2004) 0.90
Is there a link between environmental factors and a genetic predisposition to cancer? A lesson from a familial cluster of gastric cancers. Eur J Cancer (2003) 0.87
Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients. Cancer Res (1999) 0.87
Investigation of intestine function during acute viral hepatitis using combined sugar oral loads. Gut (1987) 0.87
Oesophageal acid exposure and altered neurocardiac function in patients with GERD and idiopathic cardiac dysrhythmias. Aliment Pharmacol Ther (2006) 0.86
Intravenous load of fructose and fructose 1,6-diphosphate: effects on uricemia in patients with nonalcoholic liver disease. Am J Gastroenterol (1996) 0.86
The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production. Am J Gastroenterol (2001) 0.85
Diminished active T rosette levels and increased spontaneous B lymphocyte blastogenesis in hepatitis B virus positive chronic active hepatitis. Clin Exp Immunol (1983) 0.85
Changes in intestinal permeability to lactulose induced by cytotoxic chemotherapy. Cancer Treat Rep (1982) 0.85
Bile acids reversible effects on small intestinal permeability. An in vitro study in the rabbit. Dig Dis Sci (1990) 0.84
Metabolic fate of plasma diamine oxidase: evidence of isolated and perfused rat liver uptake. Digestion (1986) 0.84
Ganglioside dependent return of TSH receptor function in a rat thyroid tumor with a TSH receptor defect. Biochem Biophys Res Commun (1983) 0.83
Serum lactate dehydrogenase isoenzyme 4/5 ratio discriminates between hepatocarcinoma and secondary liver neoplasia. Clin Chem (1991) 0.83
[Mitochondrial alterations in experimental hepatitis due to MHV 3 virus: activation and release of fumarase and rhodanese]. Riv Ist Sieroter Ital (1965) 0.82
Bovine thyroglobulin. 27 S iodoprotein interactions with thyroid membranes and formation of a 27 S iodoprotein in vitro. J Biol Chem (1982) 0.81
Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Res (1989) 0.81
Malabsorption and nutritional abnormalities in patients with liver cirrhosis. Ital J Gastroenterol (1990) 0.81
Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours. Br J Cancer (2010) 0.81
An unusual case of ascites. Dig Liver Dis (2004) 0.81
Intestinal permeability after single dose gluten challenge in coeliac disease. Arch Dis Child (1991) 0.81
Quantitative analysis of aldolase A mRNA in liver discriminates between hepatocellular carcinoma and cirrhosis. Clin Chem (2000) 0.80
Hypnosis for upper gastrointestinal endoscopy. Gastrointest Endosc (1985) 0.80
A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours. Br J Cancer (2011) 0.80
In vivo and in vitro studies of cytosolic phospholipase A2 expression in Helicobacter pylori infection. Infect Immun (2001) 0.80
[Sarcoidosis of multiregional sites with wide involvement of serous membranes. Description of a case and review of the serous pressure in sarcoidosis]. Riv Anat Patol Oncol (1967) 0.80
Role of diaphragmatic crura and lower esophageal sphincter in gastroesophageal reflux disease: manometric and pH-metric study of small hiatal hernia. Dig Dis Sci (2001) 0.80
Rat thyroid phosphofructokinase. Comparison of the regulatory and molecular properties with those of rat muscle enzyme. J Biol Chem (1979) 0.79
Brush border peptidases and arylamidases in the experimental blind loop syndrome of the rat. Acta Hepatogastroenterol (Stuttg) (1977) 0.79
Cholecystokinin and human intestinal permeability. Digestion (1980) 0.79
A novel assocation between HLA and disease: porphyria cutanea tarda and HLA-AW32. Dermatologica (1980) 0.79
Essential hypertension and chronic viral hepatitis. Dig Liver Dis (2007) 0.78
Treatment of duodenal varices by endoscopic sclerotherapy. Gastrointest Endosc (1991) 0.78
The cholecystokinin effect on human intestinal permeability: influence of chenodeoxycholic and ursodeoxycholic acid administration. Digestion (1982) 0.78
Performance characteristics of an enzyme-linked immunosorbent assay for determining salivary immunoglobulin G response to Helicobacter pylori. J Clin Microbiol (1999) 0.78
Discriminant function based on serum analytes differentiates hepatocarcinoma from secondary liver neoplasia. Clin Chem (1995) 0.77
Transformation by v-ras oncogene correlates with an increased drug-resistance in an epithelial thyroid-cell system. Int J Oncol (1995) 0.77
Levovist-enhanced Doppler sonography versus spiral computed tomography to evaluate response to percutaneous ethanol injection in hepatocellular carcinoma. J Clin Gastroenterol (2000) 0.77
Failure of endogenous gastrin release to affect serum insulin. Digestion (1973) 0.77
Molecular interactions at the cell surface: role of glycoconjugates and membrane lipids in receptor recognition processes. Prog Clin Biol Res (1982) 0.77
Prolactin secretion in nonalcoholic liver cirrhosis. Digestion (1978) 0.77
HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. Eur J Epidemiol (2001) 0.77
Differential diagnosis between hepatocellular carcinoma and cirrhosis through a discriminant function based on results for serum analytes. Clin Chem (1996) 0.77
Parietal cell hyperplasia induced by long-term administration of antacids to rats. Gut (1978) 0.77
Enzymic changes of plasma membranes isolated from mouse liver during experimental viral hepatitis. Enzymol Biol Clin (Basel) (1970) 0.77
Per-rectal portal scintigraphy with technetium-99m pertechnetate for the early diagnosis of cirrhosis in patients with chronic hepatitis. J Hepatol (1992) 0.77
Effect of Helicobacter pylori infection on gastric cell proliferation and genomic instability in a paediatric population of southern Italy. Dig Liver Dis (2001) 0.77
Nicotinamide methylation in patients with cirrhosis. J Hepatol (1994) 0.77
Manometric study of hiatal hernia and its correlation with esophageal peristalsis. Dig Dis Sci (1999) 0.76
Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin. Br J Cancer (2004) 0.76
Diagnostic efficiency in discriminating liver malignancies from cirrhosis by serum gamma-glutamyltransferase isoforms. Clin Chim Acta (1988) 0.76
Nicotinamide methylation and hepatic energy reserve: a study by liver perfusion in vitro. J Hepatol (1995) 0.76
Lymphoblastoid interferon in chronic hepatitis C patients, 'non-responders' to recombinant interferon-alpha (rIFN-alpha) J Hepatol (1992) 0.76
"Hepatic paraplegia": an uncommon complication of portosystemic shunt. Acta Neurol (Napoli) (1979) 0.76
Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study. J Viral Hepat (2001) 0.75
Pathogenic properties of Helicobacter pylori. Scand J Gastroenterol (1997) 0.75
Could immunostimulant drugs be useful in apparently medically refractory Crohn's disease? Dig Dis Sci (1994) 0.75
[Evaluation of some tolerance tests for liver functional investigations]. Rass Int Clin Ter (1969) 0.75
[The multideficiency syndrome of gastrectomized patients. Observations related to a case and etiopathological considerations]. Omnia Med Ther (1970) 0.75
The source of ascitic fluid in experimental cirrhosis in the rat. Pathol Microbiol (Basel) (1975) 0.75
Proceedings: Lysosomal changes in human and experimental iron overload. Gut (1974) 0.75
Analysis of a differential functional pattern between non-cirrhotic chronic liver disease and hepatic cirrhosis: a multivariate approach. Rev Int Hepatol (1969) 0.75
Protective effect of S-adenosyl-L-methionine in hepatic uroporphyria. Evaluation in an experimental model. Scand J Gastroenterol (1990) 0.75
Peritoneoscopy in chronic hepatitis. A retrospective evaluation of its role in the management of the asymptomatic patient. Am J Gastroenterol (1980) 0.75
[Subcellular distribution of the protein kinase activity in the normal and neoplastic thyroid tissue of the rat]. C R Seances Soc Biol Fil (1975) 0.75
Natural history of chronic viral hepatitis in southern Italy: epidemiological changes since the introduction of the anti-HCV test. Epidemiol Infect (2003) 0.75
Molecular alteration of gastric carcinoma. Minerva Gastroenterol Dietol (2002) 0.75
Phenobarbital liver microsomal induction in MHV-3 viral hepatitis of the mouse. Experientia (1972) 0.75
[Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)]. Policlinico Med (1969) 0.75
SIGE-AIGO proposals for assessing continued education and training in gastroenterology. Report of the SIGE-AIGO Working Group. Ital J Gastroenterol (1995) 0.75
Gastric pathology by Helicobacter pylori: recent advances in physiopathology diagnosis and therapy. Naples, Italy, October 20, 1995. Ital J Gastroenterol (1996) 0.75
[Behavior of some enzyme activities in the lymphocytes of the uremic patient]. Minerva Nefrol (1975) 0.75
Early biochemical evidence of neoplasm in a case of ascites of unknown origin. Clin Chem (1995) 0.75
Effect of phenobarbital on MHV-3 viral hepatitis of the mouse. Pathol Microbiol (Basel) (1973) 0.75
[Aspects of hepatic damage in diseases of the bile ducts]. Minerva Med (1969) 0.75
[Presence of various protein kinases and of partially copurified endogenous substrates in the soluble fraction of an experimental tumor of the rat thyroid gland]. C R Seances Soc Biol Fil (1975) 0.75
Adult Fanconi syndrome and liver cirrhosis. Ital J Gastroenterol (1990) 0.75
Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection. Dig Liver Dis (2003) 0.75